Take Solutions Ltd.
Snapshot View

64.05 +2.20 ▲3.6%

23 July 2021, 04:00:00 P.M.
Volume: 204,555

Overview View Details

Sector Information Technology Compare with Sector peers
Industry IT - Software Compare with Industry peers
Website http://www.takesolutions.com
Financial Indicators
Market Cap 947.52 Cr.
Earnings per share (EPS) -30.56 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2021-03
Industry PE 32.35 Trailing Twelve Months Ending 2021-03
Book Value / Share 76.04 Trailing Twelve Months Ending 2021-03
Price to Book Value 0.84 Calculated using Price: 64.05
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 14.79 Cr. 147,934,000 Shares
FaceValue 1
Company Profile

TAKE Solutions is a globally-recognized domain-leader in Life Sciences and Supply Chain Management. TAKE leverages its domain expertise, innovation-driven technology, best practices and people strength to offer clients transformative full services across clinical development, and point services in supply chain. In the fast-growing Life Sciences space, TAKE offers clients a unique combination of full-service Clinical, Regulatory and Safety services backed by unique technology expertise. Its range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry networks forums.

With a team of leading Life Sciences experts, best-in-class systems and processes, and bespoke, industry-specific technology and analytics, TAKE delivers successful outcomes for clients. Its global roster of clients includes large and small innovator biopharmaceutical companies as well as generics manufacturers. In Supply Chain Management, TAKE focuses on high-margin niches in engineering services, and supply chain collaboration. Its IP-led approach enables its clients to automate supply chain processes, track, trace & control at item level, mandate supplier compliance, and streamline material & shipment movement, and thus optimize their processes. With operations spread across North America, Europe, Asia, and South America, TAKE is a Public Company, listed in India on the Bombay Stock Exchange and the National Stock Exchange.

Business area of the company

The company delivers domain-intensive services in Life Sciences and Supply Chain Management. The company offers clients a unique combination of full service Clinical, Regulatory and Safety services with unique technology expertise. The Company's services span clinical trials to regulatory submissions to post-marketing strategy with insights derived through proprietary industry network forums.

Products and services

Life Sciences:

  • Life sciences home: implementation of clinical data standards for sponsor process enhancement and preparation of compliant clinical data. Services focused on leveraging the standardization process into Clinical Study and Summary (ISS/ISE) reports.
  • Clinical data offerings: SDTM consultation and Full clinical data lifecycle services, from CRF design to ISS/ISE.
  • Regulatory offerings: PharmaReady, an exclusive brand of TAKE Solutions, is a fully integrated web-based eDMS and eCTD Submissions Solution Suite.
  • Drug safety offerings: Complete Pharmacovigilance Safety System and Clinical Trials Safety Surveillance.

Supply Chain Management:

  • Demand Driven Supply Network
  • Demand Driven Distribution & Fulfillment
  • Mobile Applications & Auto-ID
  • Global Trade Management

Company’s technology products and solutions are:

  • Business Process Management Solutions- TAKE RTE (real time enterprise)
  • TAKE BI Solutions, the Business Intelligence practice of TAKE Solutions, delivers custom solutions that enable companies to tap the full potential of their business capabilities by helping them access, analyze and share information anytime and anywhere.
  • Microsoft solutions
  • Enterprise desktop management solutions

Awards

  • 2008: Recognized by Deloitte as India’s 10th fastest growing technology company
  • 2009: Listed in Food Logistics magazine’s FL 100+ Software & Technology Providers list for third consecutive year
  • 2010: Received MMA (Madras Management Association) award for Managerial Excellence 2010 in the Services category
  • 2010: Recognized by Supply Chain Brain as a Great Supply Chain Partner 2010 for fourth consecutive year
  • 2012: Recognized for “Significant Contribution to SCM field” at Spectrum Confluence 2012 organized by Indian Institute of Materials Management (IIMM) Chennai
  • 2012: Listed on the 2012 Supply and Demand Chain Executive 100 List for the second consecutive year
  • 2012: Recognized as TOP 100 Logistics IT Providers by Inbound Logistics magazine
  • 2013: Emerged as Asia’s Second Best Employer Brand. Declared as Best among 30 Companies from across 33 countries in Singapore
  • 2013: Recognized by Supply Chain Brain’s “2012 Great Supply Chain Partner” list
  • 2013: Named in Software Magazine’s 30th Annual Software 500 as one of the world’s largest software and service companies
  • 2013: Ranked by Inc. India magazine as one of India’s fastest growing top 500 mid-size companies
  • 2014: Won the Best Employer Brand Award at the World HRD Congress, with a total of 14 award wins
  • 2014: Named in 2013 Supply and Demand Chain Executive 100
  • 2014: Listed in Software Magazine’s 31st ‘Annual Software 500’ ranking for the second consecutive year
  • 2015: Ranked 2nd as the Dream Employer of Year, in Technology, at the World HRD Congress, with a total of 16 award wins
  • 2015: Named in Software Magazine’s 32nd Annual Software 500 ranking of the world’s largest software and service providers for the third consecutive year
  • 2016: Received a Special Commendation for Excellence in Corporate Governance at the Golden Peacock Awards
  • 2016: Declared ‘HR Company of the Year’ from amongst over 400 companies at the World HRD Congress
  • 2016: Adjudged the ‘Most Admired Brand – IT’ at the 5th Asian Customer Engagement Forum Awards that recognize excellence in Branding, Marketing and CSR
  • 2017: Received the Golden Peacock Award for Excellence in Corporate Governance
  • 2017: Chosen as one of the ‘Great Places to Work’ for its exemplary workplace culture
  • 2017: Awarded Silver recognition level by EcoVadis for Sustainability & CSR Performance
  • 2017: Received awards for the ‘Most Effective Campaign’, “Best use of video content’ and ‘Best Media Relations/PR at the prestigious Asian Customer Engagement Forum Awards
  • 2017: Received titles of ‘Dream Company to Work For’ and ‘Best Employer Brand’, and 27 other titles at the World HRD Congress
  • 2018: Won the award for Best Employer Brand for the 2nd consecutive year at the World HRD Congress 2018, and ranked 3rd in the Times Ascent presents Dream Companies to Work For category
  • 2018: Earned a place in the Great Place to Work global listing, the global authority on building, sustaining & recognizing exemplary workplace culture and best practices
  • 2018: Bestowed with the Golden Peacock Award for Excellence in Corporate Governance, for the 2nd consecutive year in 2018
  • 2019: Awarded Silver recognition level by EcoVadis for Sustainability & CSR Performance
  • 2020: CEO Insights Top 10 Clinical Trials Service Providers - 2020

Milestones

2000-2004

  • Inaugurated North American headquarters at Princeton, New Jersey, USA
  • TAKE Solutions was founded in Chennai, India

2007-2010

  • Inaugurated a state-of-the-art global delivery center in Chennai, India
  • Acquired OnSphere Corporation, Raleigh, North Carolina, USA, an IP-driven leader in regulatory compliance for Life Sciences
  • Launched OneSCM, a multi-tenant SaaS platform to improve enterprise supplier management
  • Acquired ClearOrbit, a Supply Chain Management software company in Austin, Texas, USA
  • Registered a successful IPO and listed on the Bombay Stock Exchange and the National Stock Exchange in India.

2011-2014

  • Recognized as a leader in IDC MarketScape on Drug Safety Services Worldwide Life Science Drug Safety Services 2013 Vendor Assessment
  • Acquired UK-based WCI Consulting Group, a leading patient safety and compliance advisor to the Life Sciences industry
  • Launched SafetyReady to increase the efficiency of Oracle Argus Safety Suite for Life Sciences
  • Recognized as a Leader in IDC MarketScape: Worldwide Life Sciences R&D IT Outsourcing 2011

2015

  • Launched cdsnet, a proprietary industry network on Clinical Data Strategy
  • Launched Latin American Regulatory Operations Hub in Bogota, Columbia
  • Awarded patent by the United States Patent and Trademark Office (USPTO) for “Method for Optimizing Clinical Data Standardization”
  • Launched India’s first propriety industry network on pharmacovigilance, pvindia
  • Launched pharmaReady 6.0, an update to proprietary web-based electronic document management and eSubmission solution for Life Sciences

2016

  • Acquired Ecron Acunova, a full-service CRO with Clinical & BA/BE capabilities
  • 100th pharmaReady customer win

2017

  • Navitas Life Sciences named as a Leader in IDC MarketScape: Worldwide Life Science Drug Safety Services 2017 Vendor Assessment
  • Consolidated Life Sciences businesses under the brand Navitas Life Sciences to provide full services across Clinical, Regulatory and Safety
  • Launched Labeling Assessment Express to improve End-to-End labeling for Life Sciences
  • Celebrated the landmark 15th year of its proprietary Life Sciences industry network forums
  • Updated and significantly expanded OneSCM Supply Chain Collaboration Suite
  • Launched the Gemini Series Android App for Smartphones

2018

  • Inaugurated satellite hub in Chennai to deliver end-to-end dossier submission for APAC region for one of the largest global pharma companies
  • Navitas Life Sciences recognized as ‘Leader’ in the IDC MarketScape: Drug Safety Services 2018 Vendor Assessment as one of only 8 vendors selected based on stringent research and due diligence
  • Expanded operations in Colombia to offer full-service clinical, regulatory and pharmacovigilance/safety and technology offerings across Latin America
  • Gartner recognized the Company amongst Top 20 Global Solution Providers in its Market Guide for Track-and-Trace and Serialization Software Providers for Life Sciences Companies
  • TAKE recognised in CIO Review’s ‘20 Most Promising Pharma and Life Sciences Tech Companies'
  • Inaugurated state-of-the-art Clinical facility in Chennai to conduct Bioavailability & Bioequivalence studies

2019-20

  • Everest Group's Life Sciences Clinical Trials Products PEAK Matrix Assessment 2019 recognized Navitas Life Sciences as a Major Contender
  • Acquired US-based, full-service contract research organization (CRO) and health-research company KAI Research
  • Acquired DataCeutics, an American Clinical Data Sciences services company that provides quality SAS based statistical programming, clinical reporting and clinical data management
  • 175+ customers for pharmaREADY, its cloud-based Regulatory Submissions management platform

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+3.56%
1 Week
-1.39%
1 Month
-7.44%
3 Month
+29.79%
6 Month
+11.68%
1 Year
+54.71%
2 Year
-41.64%
5 Year
-62.54%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 31.58 23.38 13.88 16.08 21.61 19.05 14.37 12.61 -0.71
Return on Capital Employed (%) 27.40 21.14 11.84 13.91 18.78 17.74 14.91 13.21 1.38
Return on Assets (%) 14.18 11.30 7.27 8.96 11.69 11.32 9.96 8.55 -0.46

Balance Sheet View Details

Particulars 9 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Shh. Funds 420 470 524 631 911 1,328 1,518 1,575 1,125
Non Curr. Liab. 113 82 26 99 81 89 80 219 178
Curr. Liab. 258 262 316 443 336 415 724 660 524
Minority Int. 46 48 56 40 42 8 9 10 0
Equity & Liab. 837 862 922 1,214 1,369 1,840 2,331 2,464 1,826
Non Curr. Assets 376 401 397 587 590 662 1,159 1,266 965
Curr. Assets 460 461 525 626 779 1,178 1,172 1,199 861
Misc. Exp. not W/O
Total Assets 837 862 922 1,214 1,369 1,840 2,331 2,464 1,826

Profit Loss View Details

Particulars 9 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Net Sales 832 816 730 1,030 1,345 1,587 2,039 2,213 777
Other Income 7 6 8 21 13 6 11 26 12
Total Income 839 822 739 1,051 1,357 1,594 2,050 2,239 789
Total Expenditure -671 -668 -620 -866 -1,082 -1,281 -1,656 -2,044 -847
PBIDT 168 153 118 185 275 313 394 195 -58
Interest -14 -14 -13 -15 -23 -21 -25 -41 -37
Depreciation -46 -77 -20 -25 -87 -104 -154 -167 -115
Taxation -18 -1 -5 -20 -19 -28 -37 2 -14
Exceptional Items -225
PAT 89 62 80 125 146 160 178 -11 -450

Cash Flow View Details

Particulars 9 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 117 100 74 148 56 121 104 211 135
Cash Fr. Inv. -70 -91 -16 -257 -129 -179 -485 -236 -57
Cash Fr. Finan. -31 -7 -11 114 56 302 100 21 -84
Net Change 16 2 46 5 -17 244 -281 -4 -6
Cash & Cash Eqvt 70 72 121 91 74 317 47 45 39

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 66.89 66.89 66.89 66.89 58.65 53.41 53.41 53.41 53.41
Public 33.11 33.11 33.11 33.11 41.35 46.59 46.59 46.59 46.59
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Fri, 23 Jul 2021
Submission Of Half Yearly Disclosure On Related Party Transactions
In Compliance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) (Amendments) Regulations 2018 we hereby submit a note on Related Party Transactions on consolidated basis for the half year ended March 31 2021 drawn in accordance with applicable accounting standards.
Fri, 23 Jul 2021
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith copies of the Notice of the 20th (Twentieth) Annual General Meeting of the Company to be held on August 11 2021 published in newspapers namely Financial express (English) and Makkal Kural (Tamil) dated July 21 2021.

Kindly take the same on record and acknowledge.
Thu, 22 Jul 2021
Annual General Meeting And Book Closure
We wish to inform that the Twentieth Annual General Meeting of the Shareholders of TAKE Solutions Limited will be held on Wednesday August 11 2021 at 11.00 a.m. IST. through Video Conferencing (VC) /Other Audio-Visual Means (OAVM) to transact the business as set out in the notice convening the said Annual General Meeting which was already mailed to all the shareholders of the Company.

We further wish to inform you that the Register of Members and Share Transfer Books of the Company will remain closed from Wednesday August 4 2021 to Wednesday August 11 2021 (both days inclusive).

Technical Scans View Details

Fri, 23 Jul 2021
Decreasing Relative Strength - Benchmark index Decreasing Relative Strength - Benchmark index
Decreasing Relative Strength - Sectoral index Decreasing Relative Strength - Sectoral index
Both SRS And ARS Above Zero Both SRS And ARS Above Zero
Either SRS Or ARS Going Above Zero Either SRS Or ARS Going Above Zero
ARS Higher Than 0 & SRS Going Above Zero ARS Higher Than 0 & SRS Going Above Zero

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Tata Consultancy Services Ltd. 1,188,153.80 3,212.05 -0.1%
Infosys Ltd. 675,362.45 1,590.35 +0.0%
Wipro Ltd. 328,288.66 599.15 +2.6%
HCL Technologies Ltd. 269,806.15 994.25 +1.6%
Tech Mahindra Ltd. 109,481.27 1,129.70 -1.6%
Zomato Ltd. 98,731.59 125.85 0%
Larsen & Toubro Infotech Ltd. 76,198.93 4,352.05 -1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Tata Consultancy Services Ltd. Consolidated 2021-06 34.51 3,212.05 -0.1%
Infosys Ltd. Consolidated 2021-06 33.25 1,590.35 +0.0%
Wipro Ltd. Consolidated 2021-06 28.18 599.15 +2.6%
HCL Technologies Ltd. Consolidated 2021-06 23.63 994.25 +1.6%
Tech Mahindra Ltd. Consolidated 2021-03 24.72 1,129.70 -1.6%
Zomato Ltd. Standalone 2021-03 0.00 125.85 0%
Larsen & Toubro Infotech Ltd. Consolidated 2021-06 37.80 4,352.05 -1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Tata Consultancy Services Ltd. Consolidated 2021-06 12.56 3,212.05 -0.1%
Infosys Ltd. Consolidated 2021-06 8.32 1,590.35 +0.0%
Wipro Ltd. Consolidated 2021-06 5.68 599.15 +2.6%
HCL Technologies Ltd. Consolidated 2021-06 4.27 994.25 +1.6%
Tech Mahindra Ltd. Consolidated 2021-03 4.48 1,129.70 -1.6%
Zomato Ltd. Standalone 2021-03 5.79 125.85 0%
Larsen & Toubro Infotech Ltd. Consolidated 2021-06 9.83 4,352.05 -1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Tata Consultancy Services Ltd. Consolidated 2021-03 0.00 3,212.05 -0.1%
Infosys Ltd. Consolidated 2021-03 0.00 1,590.35 +0.0%
Wipro Ltd. Consolidated 2021-03 0.15 599.15 +2.6%
HCL Technologies Ltd. Consolidated 2020-03 0.10 994.25 +1.6%
Tech Mahindra Ltd. Consolidated 2021-03 0.07 1,129.70 -1.6%
Zomato Ltd. Standalone 2021-03 0.00 125.85 0%
Larsen & Toubro Infotech Ltd. Consolidated 2021-03 0.01 4,352.05 -1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Tata Consultancy Services Ltd. Consolidated 2021-03 38.55 3,212.05 -0.1%
Infosys Ltd. Consolidated 2021-03 27.52 1,590.35 +0.0%
Wipro Ltd. Consolidated 2021-03 19.78 599.15 +2.6%
HCL Technologies Ltd. Consolidated 2020-03 23.87 994.25 +1.6%
Tech Mahindra Ltd. Consolidated 2021-03 19.01 1,129.70 -1.6%
Zomato Ltd. Standalone 2021-03 -21.84 125.85 0%
Larsen & Toubro Infotech Ltd. Consolidated 2021-03 30.79 4,352.05 -1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Tata Consultancy Services Ltd. Consolidated 2021-03 52.56 3,212.05 -0.1%
Infosys Ltd. Consolidated 2021-03 37.83 1,590.35 +0.0%
Wipro Ltd. Consolidated 2021-03 22.79 599.15 +2.6%
HCL Technologies Ltd. Consolidated 2020-03 28.42 994.25 +1.6%
Tech Mahindra Ltd. Consolidated 2021-03 22.98 1,129.70 -1.6%
Zomato Ltd. Standalone 2021-03 -18.27 125.85 0%
Larsen & Toubro Infotech Ltd. Consolidated 2021-03 41.73 4,352.05 -1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Tata Consultancy Services Ltd. Consolidated 2021-03 164,177.00 3,212.05 -0.1%
Infosys Ltd. Consolidated 2021-03 100,472.00 1,590.35 +0.0%
Wipro Ltd. Consolidated 2021-03 61,943.00 599.15 +2.6%
HCL Technologies Ltd. Consolidated 2020-03 70,676.00 994.25 +1.6%
Tech Mahindra Ltd. Consolidated 2021-03 37,855.10 1,129.70 -1.6%
Zomato Ltd. Standalone 2021-03 1,993.79 125.85 0%
Larsen & Toubro Infotech Ltd. Consolidated 2021-03 12,369.80 4,352.05 -1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Tata Consultancy Services Ltd. Consolidated 2021-03 32,562.00 3,212.05 -0.1%
Infosys Ltd. Consolidated 2021-03 19,423.00 1,590.35 +0.0%
Wipro Ltd. Consolidated 2021-03 10,855.00 599.15 +2.6%
HCL Technologies Ltd. Consolidated 2020-03 11,057.00 994.25 +1.6%
Tech Mahindra Ltd. Consolidated 2021-03 4,351.80 1,129.70 -1.6%
Zomato Ltd. Standalone 2021-03 -816.43 125.85 0%
Larsen & Toubro Infotech Ltd. Consolidated 2021-03 1,938.20 4,352.05 -1.1%